ArticleTherapeutic innovation & regulatory science2024

A Survey to Assess the Current Status of Structured Benefit-Risk Assessment in the Global Drug and Medical Device Industry.

Martin Gebel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.